Global Alzheimer’s Therapeutics Market Professional Survey Report 2018

Global Alzheimer’s Therapeutics Market Professional Survey Report 2018

Press Release

Alzheimer’s disease (AD), also referred to simply as Alzheimer’s, is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60% to 70% of cases of dementia.

Europe is estimated to grow at a rapid pace owing to the high prevalence of AD coupled with ever-improving diagnostic capabilities. Asia Pacific is expected to witness the fastest growth over the forecast period owing to the rising disposable income level.

The global Alzheimers Therapeutics market is valued at xx million US$ in 2017 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2018-2025.

Global Alzheimer’s Therapeutics Market Professional Survey Report 2018 is a professional and in-depth study and available exclusively through Trusted Business Insights. Annual estimates and forecasts are provided for the period 2018 through 2025. Also, a five-year historic analysis is provided for these markets in this 110 pages report.

This market report provides in-depth analytics of the Alzheimer’s Therapeutics industry including definition, classification, application and industry chain structure. The report focuses on global major leading industry players with information such as company profiles, product picture and specifications, sales, market share, and contact information.

Request for a Sample PDF of Alzheimer’s Therapeutics research report

Alzheimer’s Therapeutics market report includes an in-depth analysis of the competitive landscape of this business vertical, constituting companies like:

Pfizer, Inc.
Merck & Co. Inc.
Novartis AG
Eisai Co. Ltd.
H. Lundbeck A/S
AC Immune
TauRx Pharmaceuticals Ltd.
Actavis plc.
Forest Laboratories
Teva Pharmaceuticals Industries Ltd.
Janssen Pharmaceutical
GE healthcare
Eli Lilly And Company
DiaGenic ASA
VTV Therapeutics
Hoffman-La Roche Ltd.
AstraZeneca
Daiichi Sankyo Company Ltd.

Products Segmentation, this report displays the production, revenue, price, market share, and growth rate of each type as below:

Donepezil
Memantine
Rivastigmine

By Industrial Application, the market can be split into:

Early to Moderate Stages
Moderate to Severe Stages

Market Segment by Regions includes:

  • North America (the USA, Canada, and Mexico)
  • Europe (Germany, France, UK, Russia, and Italy)
  • Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)
  • South America
  • Middle East and Africa.

Browse contents of Global Alzheimer’s Therapeutics Market Professional Survey Report 2018

Contacts

Trusted Business Insights
Shelly Arnold
Blogger & Influencer Marketing Executive
US: +1 646 568 9797
UK: +44 330 808 0580

Tags: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,